Open Access
Vet. Res.
Volume 37, Number 3, May-June 2006
Mucosal immunology in domestic animals
Page(s) 511 - 539
Published online 14 April 2006
How to cite this article Vet. Res. (2006) 511-539
References of Vet. Res. 37 (2006) 511-539
  1. Abel G., Czop J.K., Stimulation of human monocyte beta-glucan receptors by glucan particles induces production of TNF-alpha and IL-1, Int. J. Immunopharmacol. 14 (1992) 1363-1373 [CrossRef] [PubMed].
  2. Agren L.C., Ekman L., Lowenadler B., Lycke N.Y., Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit, J. Immunol. 158 (1997) 3936-3946 [PubMed].
  3. Agren L.C., Ekman L., Lowenadler B., Nedrud J.G., Lycke N.Y., Adjuvanticity of the cholera toxin A1-based fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity, J. Immunol. 162 (1999) 2432-2440 [PubMed].
  4. Agren L., Sverremark E., Ekman L., Schon K., Lowenadler B., Fernandez C., Lycke N.Y., The ADP-ribosylating CTA1-DD adjuvant enhances T-cell dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects, J. Immunol. 164 (2000) 6276-6286 [PubMed].
  5. Alroy I., Towers T.L., Freedman L.P., Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor, Mol. Cell. Biol. 15 (1995) 5789-5799 [PubMed].
  6. Anastassiou E.D., Yamada H., Francis M.L., Mond J.J., Tsokos G.C., Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation, J. Immunol. 145 (1990) 2375-2380 [PubMed].
  7. Ashkar A.A., Bauer S., Mitchell W.J., Vieira J., Rosenthal K.L., Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2, J. Virol. 77 (2003) 8948-8956 [CrossRef] [PubMed].
  8. Babiuk L.A., van Drunen Littel-van den Hurk S., Loehr B.I., Uwiera R., Veterinary applications of DNA vaccines, Dev. Biol. 104 (2000) 73-81.
  9. Bagley K.C., Abdelwahab S.F., Tuskan R.G., Fouts T.R., Lewis G.K., Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway, Infect. Immun. 70 (2002) 5533-5539 [CrossRef] [PubMed].
  10. Barackman J.D., Ott G., Pine S., O'Hagan D.T., Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization, Clin. Diagn. Lab. Immunol. 8 (2001) 652-657 [CrossRef] [PubMed].
  11. Baran D.T., Sorensen A.M., Rapid actions of 1 alpha-25-dihydroxyvitamin D3 physiologic role, Proc. Soc. Exp. Biol. Med. 207 (1994) 175-179 [PubMed].
  12. Becker P.D., Corral R.S., Guzman C.A., Grinstein S., Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice, Vaccine 19 (2001) 4603-4609 [CrossRef] [PubMed].
  13. Benach J.L., Habicht G.S., Holbrook T.W., Cook J.A., Glucans as an adjuvant for a murine Babesea microti immunization trail, Infect. Immun. 35 (1982) 947-951 [PubMed].
  14. Bergström-Mollaoglu M., Lövgren K., Akerblom L., Fossum C., Morein B., Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms, Scand. J. Immunol. 36 (1992) 565-574 [PubMed].
  15. Boyaka P.N., Marinaro M., Jackson R.J., et al., Oral QS-21 requires early IL-4 help for the induction of mucosal and systemic immunity, J. Immunol. 166 (2001) 2283-2290 [PubMed].
  16. Boyaka P.N., Ohmura M., Fujihashi K., Koga T., Yamamoto M., Kweon M.N., Takeda Y., Jackson R.J., Kiyono H., Yuki Y., McGhee J.R., Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit, J. Immunol. 170 (2003) 454-462 [PubMed].
  17. Bone H., Eckholdt S., Williams N.A., Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin, Int. Immunol. 14 (2002) 647-658 [CrossRef] [PubMed].
  18. Bowman C.C., Clements J.D., Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids, Infect. Immun. 69 (2001) 1528-1535 [CrossRef] [PubMed].
  19. Braun M.C., He J., Wu C.Y., Kelsall B.L., Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain espresso, J. Exp. Med. 189 (1999) 541-552 [CrossRef] [PubMed].
  20. Bromander A., Holmgren J., Lycke N., Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro, J. Immunol. 146 (1991) 2908-2914 [PubMed].
  21. Bromander A.K., Kjerrulf M., Holmgren J., Lycke N., Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells, Scand. J. Immunol. 37 (1993) 452-458 [PubMed].
  22. Brown G.D., Gordon S., Immune recognition: a new receptor for beta-glucans, Nature 413 (2001) 36-37 [CrossRef].
  23. Brown W.C., Estes D.M., Chantler S.E., Keggerreis K.A., Suarez C.E., DNA and CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells, Infect. Immun. 66 (1998) 5423-5432 [PubMed].
  24. Burkart V., Kim Y.E., Hartmann B., Ghiea I., Syldath U., Kauer M., Fingberg W., Hanifi-Moghaddam P., Muller S., Kolb H., Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide, J. Immunol. 168 (2002) 1730-1737 [PubMed].
  25. Cardon L.R., Burge C., Claydon D.A., Karlin S., Pervasive CpG suppression in animal mitochondrial genomes, Proc. Natl. Acad. Sci. USA 91 (1994) 3799-3803 [CrossRef] [PubMed].
  26. Carol H., Nieto A., A mucosal IgA response, but no systemic antibody response is evoked by intranasal immunization of dogs with Echinococcus granulosus surface antigens ISCOMs, Vet. Immunol. Immunopathol. 65 (1998) 29-41 [PubMed].
  27. Chan V.W., Mecklenbrauker I., Su I., Texido G., Leitges M., Carsetti R., Lowell C.A., Rajewsky K., Miyake K., Tarakhovsky A., The molecular mechanism of B cell activation by Toll-like receptor protein RP-105, J. Exp. Med. 188 (1998) 93-101 [CrossRef] [PubMed].
  28. Chen D., Colditz I.G., Glenn G.M., Tsonis C.G., Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep, Vet. Immunol. Immunopathol. 86 (2002) 177-182 [PubMed].
  29. Chen P., Li J., Barnes J., Kokkonen G.C., Lee J.C., Liu Y., Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages, J. Immunol. 169 (2002) 6408-6416 [PubMed].
  30. Childers N.K., Miller K.L., Tong G., Llarena J.C., Greenway T., Ulrich J.T., Michalek S.M., Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen, Infect. Immun. 68 (2000) 5509-5516 [CrossRef] [PubMed].
  31. Chong C., Friberg M., Clements J.D., LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp., Vaccine 16 (1998) 732-740 [CrossRef] [PubMed].
  32. Chu R.S., Askew D., Noss E.H., Tobian A., Krieg A.M., Harding C.V., CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing, J. Immunol. 163 (1999) 1188-1194 [PubMed].
  33. Cippitelli M., Santoni A., Vitamin D3: a transcriptional modulator of the interferon-gamma gene, Eur. J. Immunol. 28 (1998) 3017-3030 [PubMed].
  34. Claassen I.J., Osterhaus A.D., Poelen M., Van Rooijen N., Claassen E., Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent, Immunology 94 (1998) 455-460 [PubMed].
  35. Clements J.D., Hartzog N.M., Lyon F.L., Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens, Vaccine 6 (1988) 269-277 [CrossRef] [PubMed].
  36. Confer A.W., Suckow M.A., Montelongo M., Dabo S.M., Miloscio L.J., Gillespie A.J., Meredith GL Intranasal vaccination of rabbits with Pasteurella multocida A:3 outer membranes that express iron-regulated proteins, Am. J. Vet. Res. 62 (2001) 697-703 [PubMed].
  37. Cong Y., Weaver C.T., Elson C.O., The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression, J. Immunol. 159 (1997) 5301-5308 [PubMed].
  38. Cong Y., Oliver A.O., Elson C.O., Effects of cholera toxin on macrophage production of co-stimulatory cytokines, Eur. J. Immunol. 31 (2001) 64-71 [PubMed].
  39. Coulter A., Harris R., Davis R., Drane D., Cox J., Ryan D., Sutton P., Rockman S., Pearse M., Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine, Vaccine 21 (2003) 946-949 [CrossRef] [PubMed].
  40. Cox E., Houvenaghel A., Cools V., Schrauwen E., Experimental induction of diarrhea in newly-weaned piglets, J. Vet. Med. B 38 (1991) 418-426.
  41. Cox J.C., Coulter A.R., Adjuvants - a classification and review of their modes of action, Vaccine 15 (1997) 248-256 [CrossRef] [PubMed].
  42. Dalsgaard K., Saponin adjuvants. III Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in foot-and-mouth disease vaccines, Arch. Gesamte Virusforsch. 44 (1974) 243-254 [CrossRef] [PubMed].
  43. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di Lucia P., Lang R., Sinigaglia F., Panina-Bordignon P., Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF$\kappa$B downregulation in transcriptional repression of the p40 gene, J. Clin. Invest. 101 (1998) 252-262 [PubMed].
  44. Da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J., Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer From CD14 to TLR4 and MD-2, J. Biol. Chem. 276 (2001) 21129-21135 [CrossRef] [PubMed].
  45. Daynes R.A., Enioutina E.Y., Butler S., Mu H.H., McGee Z.A., Araneo B.A., Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization, Infect. Immun. 64 (1996) 1100-1109 [PubMed].
  46. De Haan L., Feil I.K., Verweij W.R., Holtrop M., Hol W.G., Agsteribbe E., Wilschut J., Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin, Eur. J. Immunol. 28 (1998) 1243-1250 [PubMed].
  47. De Haan L., Verweij W.R., Feil I.K., Holtrop M., Hol W.G., Agsteribbe E., Wilschut J., Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit, Immunology 94 (1998) 424-430 [PubMed].
  48. De Jong E.C., Vieira P.L., Kalinski P., Schuitemaker J.H., Tanaka Y., Wierenga E.A., Yazdanbakhsh M., Kapsenberg M.L., Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals, J. Immunol. 168 (2002)1704-1709.
  49. Dickinson B.L., Clements J.D., Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity, Infect. Immun. 63 (1995) 1617-1623 [PubMed].
  50. Doita M., Rasmussen L.T., Seljelid R., Lipsky P.E., Effect of soluble aminated beta-1,3-D-polyglucose on human monocytes: stimulation of cytokine and prostaglandin E2 production but not antigen-presenting function, J. Leukoc. Biol. 49 (1991) 342-351 [PubMed].
  51. Domeika K., Magnusson M., Eloranta M.L., Fuxler L., Alm G.V., Fossum C., Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells, Vet. Immunol. Immunopathol. 101 (2004) 87-102 [PubMed].
  52. Douce G., Fontana M., Pizza M., Rappuoli R., Dougan G., Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin, Infect. Immun. 65 (1997) 2821-2828 [PubMed].
  53. Eaton-Bassiri A., Dillon S.B., Cunningham M., Rycyzyn M.A., Mills J., Sarisky R.T., Mbow M.L., Toll-Like Receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells, Infect. Immun. 72 (2004) 7202-7211 [CrossRef] [PubMed].
  54. Edelman R., Tacket C.O., Adjuvants, Int. Rev. Immunol. 7 (1990) 51-66 [PubMed].
  55. Eriksson K., Fredriksson M., Nordstrom I., Holmgren J., Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development, Infect. Immun. 71 (2003) 1740-1747 [CrossRef] [PubMed].
  56. Elson C.O., Ealding W., Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin, J. Immunol. 132 (1984) 2736-2741 [PubMed].
  57. Elson C.O., Holland S.P., Dertzbaugh M.T., Cuff C.F., Anderson A.O., Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit, J. Immunol. 154 (1995) 1032-1040 [PubMed].
  58. Elstad M.R., Cowley P.F.S., Wilcox L.A., McIntyre T.M., Prescott S.M., Zimmerman G.A., CD11b/CD18 integrin and a ß-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes, J. Immunol. 152 (1994) 220-230 [PubMed].
  59. Enioutina E.Y., Visic D., McGee Z.A., Daynes R.A., The induction of systemic and mucosal immune responses following the subcutaneous immunisation of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant, Vaccine 17 (1999) 3050-3064 [CrossRef] [PubMed].
  60. Enioutina E.Y., Visic D., Daynes R.A., The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity, Vaccine 18 (2000) 2753-2767 [CrossRef] [PubMed].
  61. Feng W., Wang Y., Zhang J., Wang X., Li C., Chang Z., Effects of CTx and 8-bromo-cAMP on LPS-induced gene expression of cytokines in murine peritoneal macrophages, Biochem. Biophys. Res. Commun. 269 (2000) 570-573 [CrossRef] [PubMed].
  62. Finerty S., Stokes C.R., Gruffydd-Jones T.J., Hillman T.J., Reeves N.A., Whiting C.V., Schaaper W.M., Dalsgaard K., Harbour D.A., Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge, Vaccine 18 (2000) 3254-3265 [CrossRef] [PubMed].
  63. Foss D.L., Murtaugh M.P., Mucosal immunogenicity and adjuvanticity of cholera toxin in swine, Vaccine 17 (1999) 788-801 [CrossRef] [PubMed].
  64. Foss D.L., Zilliox M.J., Murtaugh M.P., Differential regulation of macrophage interleukin-1 (IL-1), IL-12 and CD80-CD86 by two bacterial toxins, Infect. Immun. 67 (1999) 5275-5281 [PubMed].
  65. Francis M.L., Ryan J., Jobling M.G., Holmes R.K., Moss J., Mond J.J., Cyclic AMP-independent effects of cholera toxin on B cell activation: II. Binding of ganglioside GM1 induces B cell activation, J. Immunol. 148 (1992) 1999-2005 [PubMed].
  66. Fukuta S., Magnani J.L., Twiddy E.M., Holmes R.K., Ginsburg V., Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-Iib, Infect. Immun. 56 (1988) 1748-1753 [PubMed].
  67. Gagliardi M.C., De Magistris M.T., Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression, Vaccine 21 (2003) 856-861 [CrossRef] [PubMed].
  68. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., Underhill D.M., Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2, J. Exp. Med. 197 (2003) 1107-1117 [CrossRef] [PubMed].
  69. Gerber S., Lane C., Brown D.M., Lord E., DiLorenzo M., Clements J.D., Rybicki E., Williamson A.L., Rose R.C., Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA, J. Virol. 75 (2001) 4752-4760 [CrossRef] [PubMed].
  70. Gerdts W., Mutwiri G.K., Tikoo S.K., Babiuk L.A., Mucosal delivery of vaccines in domestic animals, Vet. Res. 37 (2006) 487-510 [CrossRef] [PubMed] [EDP Sciences].
  71. Gill D.M., Rappaport R.S., Origin of the enzymatically active A1 fragment of cholera toxin, J. Infect. Dis. 139 (1979) 674-680 [PubMed].
  72. Girard F., Pery P., Naciri M., Quere P., Adjuvant effect of cholera toxin on systemic and mucosal immune responses in chickens infected with E. tenella or given recombinant parasitic antigen per os, Vaccine 17 (1999) 1516-1524 [CrossRef] [PubMed].
  73. Gizurarson S., Tamura S., Aizawa C., Kurata T., Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit, Vaccine 10 (1992) 101-106 [CrossRef] [PubMed].
  74. Glenn G.M., Rao M., Matyas G.R., Alving C.R., Cholera toxin opens up skin immunization route, Nature 391 (1998) 851 [CrossRef] [PubMed].
  75. Glenn G.M., Scharton-Kersten T., Vassell R., Mallett C.P., Hale T.L., Alving C.R., Transcutaneous immunization with cholera toxin protects mice against lethal mucosal challenge, J. Immunol. 161 (1998) 3211-3214 [PubMed].
  76. Glenn G.M., Taylor D.N., Frakel S., Montermarano A., Alving C.R., Transcutaneous immunization: a human vaccine delivery strategy using a patch, Nat. Med. 6 (2000) 1403-1406 [CrossRef] [PubMed].
  77. Glenny A.T., Pope C.G., Waddington H., Wallace U., Immunological notes, J. Pathol. Bacteriol. 29 (1926) 31-40 [CrossRef].
  78. Goddeeris B.M., Boersma W.J.A., Cox E., Mast J., Van der Stede Y., Koenen M.E., Vancaeneghem S., Mast J., Van den Broeck W., The porcine and avian intestinal immune system and its nutritional modulation, in: Blok M.C., Vahl H.A., de Lange L., van de Braak A.E., Hemke G., Hessing M. (Eds.), Nutrition and health of the gastrointestinal tract, Wageningen Academic publishers, 2002, pp. 97-134.
  79. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., Potter A., Protection of chickens against Escherichia coli infections by DNA containing CpG motifs, Infect. Immun. 71 (2003) 857-863 [CrossRef] [PubMed].
  80. Gonzalez A.M., Nguyen T.V., Azevedo M.S., Jeong K., Agarib F., Iosef C., Chang K., Lovgren-Bengtsson K., Morein B., Saif L.J., Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM, Clin. Exp. Immunol. 135 (2004) 361-372 [PubMed].
  81. Hammond S.A., Tsonis C., Sellins K., Rushlow K., Scharton-Kersten T., Colditz I., Glenn G.M., Transcutaneous immunization of domestic animals: opportunities and challenges, Adv. Drug Deliv. Rev. 43 (2000) 45-55 [CrossRef] [PubMed].
  82. Harant H., Andrew P.J., Reddy G.S., Foglar E., Lindley I.J., 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression, Eur. J. Biochem. 250 (1997) 63-71 [PubMed].
  83. Hartmann G., Krieg A.M., Mechanism and function of a newly identified CpG-DNA motif in human primary B-cells, J. Immunol. 164 (2000) 944-953 [PubMed].
  84. Hasslung F.C., Berg M., Allan G.M., Meehan B.M., McNeilly F., Fossum C., Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN-alpha production by porcine PBMCs, J. Gen. Virol. 84 (2003) 2937-2945 [CrossRef] [PubMed].
  85. He H., Lowry V.K., Swaggerty C.L., Ferro P.J., Kogut M.H., In vitro activation of chicken leukocytes and in vivo protection against Salmonella enteritidis organ invasion and peritoneal S. enteritidis infection-induced mortality in neonatal chickens by immunostimulatory CpG oligodeoxynucleotide, FEMS Immunol. Med. Microbiol. 43 (2005) 81-89 [PubMed].
  86. Hemmi H., Takeuchi O., Kawai T., Kaiso T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S., A Toll-like receptor recognizes bacterial DNA, Nature 408 (2000) 740-745 [CrossRef] [PubMed].
  87. Höglund S., Dalsgaard K., Lövgren K., Sundquist B., Osterhaus A., Morein B., ISCOMs and immunostimulation with viral antigens, Subcell. Biochem. 15 (1989) 39-68 [PubMed].
  88. Holmgren J., Lonnroth I., Svennerholm L., Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids, Infect. Immun. 8 (1973) 208-214 [PubMed].
  89. Holmgren J., Fredman P., Lindblad M., Svennerholm A.M., Svennerholm L., Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin, Infect. Immun. 38 (1982) 424-433 [PubMed].
  90. Horner A.A., Ronaghy A., Cheng P.M., Nguyen M.D., Cho H.J., Broide D., Raz E., Immunostimulatory DNA is a potent mucosal adjuvant, Cell. Immunol. 190 (1998) 77-82 [CrossRef] [PubMed].
  91. Hornquist E., Lycke N., Cholera toxin adjuvant greatly promotes antigen priming of T cells, Eur. J. Immunol. 23 (1993) 2136-2143 [PubMed].
  92. Hu K.F., Ekstrom J., Merza M., Lovgren-Bengtsson K., Morein B., Induction of antibodies in the common mucosal immune system by respiratory syncytial virus immuno-stimulating complexes, Med. Microbiol. Immunol. (Berl.) 187 (1999) 191-198.
  93. Hoshi S., Nakamura T., Nunoya T., Ueda S., Induction of protective immunity in chickens orally immunized with inactivated infectious bursal disease virus, Vaccine 13 (1995) 245-252 [CrossRef] [PubMed].
  94. Hyland K., Foss D.L., Johnson C.R., Murtaugh M.P., Oral immunization induces local and distant mucosal immunity in swine, Vet. Immunol. Immunopathol. 102 (2004) 329-338 [PubMed].
  95. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S., CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein, Vaccine 21 (2002) 127-137 [CrossRef] [PubMed].
  96. Iosef C., Van Nguyen T., Jeong K., Bengtsson K., Morein B., Kim Y., Chang K.O., Azevedo M.S., Yuan L., Nielsen P., Saif L.J., Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes, Vaccine 20 (2002) 1741-1753 [CrossRef] [PubMed].
  97. Iwasaki A., Kelsall B.L., Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine, J. Exp. Med. 191 (2000) 1381-1394 [CrossRef] [PubMed].
  98. Jackson R.J., Fujihashi K., Xu-Amano J., Kiyono H., Elson C.O., McGhee J.R., Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant, Infect. Immun. 61 (1993) 4272-4279 [PubMed].
  99. Jacobs H.J., Wiltshire C., Ashman K., Meeusen E.N., Vaccination against the gastrointestinal nematode, Haemonchus contortus, using a purified larval surface antigen, Vaccine 17 (1999) 362-368 [CrossRef] [PubMed].
  100. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C., Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA, J. Immunol. 161 (1998) 3042-3049 [PubMed].
  101. Jeurissen S.H., Sminia T., Beuvery E.C., Induction of mucosal immunoglobulin A immune response by preparations of Neisseria gonorrhoea porin proteins, Infect. Immun. 55 (1987) 253-257 [PubMed].
  102. John M., Bridges E.A., Miller A.O., Calderwood S.B., Ryan E.T., Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies, Vaccine 20 (2002) 2720-2726 [CrossRef] [PubMed].
  103. Johnson A.J., Gaines S., Landy M., Studies on the O antigen of Salmonella typhosa. V. Enhancement of the antibody response to protein antigens by the purified lipopolysaccharide, J. Exp. Med. 103 (1956) 225-233 [CrossRef] [PubMed].
  104. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J., Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens, J. Exp. Med. 194 (2001) 863-869 [CrossRef] [PubMed].
  105. Kamiya N., Asano Y., Yoshino J., Sasaki K., Honma Y., Kawase H., Yokochi T., Shiraki K., Tsuji T., Long-term persistence of cellular immunity to Oka vaccine virus induced by pernasal co-administration with Escherichia coli enterotoxin in mice, Vaccine 19 (2001) 3131-3136 [CrossRef] [PubMed].
  106. Kamstrup S., Verthelyi D., Klinman D.M., Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides, Vet. Microbiol. 78 (2001) 353-362 [CrossRef] [PubMed].
  107. Kandimalla E.R., Bhagat L., Zhu F.G., Yu D., Cong Y.P., Wang D., Tang J.X., Tang J.Y., Knetter C.F., Lien E., Agrawal S., A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif, Proc. Natl. Acad. Sci. USA 100 (2003) 14303-14308 [CrossRef] [PubMed].
  108. Kang S.M., Yao Q., Guo L., Compans R.W., Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B, J. Virol. 77 (2003) 9823-9830 [CrossRef] [PubMed].
  109. Kawamura Y.I., Kawashima R., Shirai Y., Kato R., Hamabata T., Yamamoto M., Furukawa K., Fujihashi K., McGhee J.R., Hayashi H., Dohi T., Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF- B translocation, Eur. J. Immunol. 33 (2003) 3205-3212 [PubMed].
  110. Kensil C.R., Patel U., Lennick M., Marciani D., Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex, J. Immunol. 146 (1991) 431-437 [PubMed].
  111. Kim P.H., Eckmann L., Lee W.J., Han W., Kagnoff M.F., Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-ß1, J. Immunol. 160 (1998) 1198-1203 [PubMed].
  112. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M., CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma, Proc. Natl. Acad. Sci. USA 93 (1996) 2879-2883 [CrossRef] [PubMed].
  113. Klinman D.M., Yamshichikov G., Ishigatsubo Y., Contribution of CpG motifs to the immunogenicity of DNA-vaccines, J. Immunol. 158 (1997) 3635-3639 [PubMed].
  114. Klipstein F.A., Engert R.F., Houghten R.A., Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit, Infect. Immun. 40 (1983) 888-893 [PubMed].
  115. Kokuryo S., Inoue H., Fukuizumi T., Tsujisawa T., Tominaga K., Fukuda J., Evaluation of interleukin 1 as a mucosal adjuvant in immunization with Streptococcus sobrinus cells by tonsillar application in rabbits, Oral Microbiol. Immunol. 17 (2002) 163-171 [PubMed].
  116. Kraehenbuhl J.P., Neutra M.R., Epithelial M cells: differentiation and function, Annu. Rev. Cell Dev. Biol. 16 (2000) 301-332 [PubMed].
  117. Krieg A.M., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M., CpG motifs in bacterial DNA trigger direct B-cell activation, Nature 374 (1995) 546-549 [CrossRef] [PubMed].
  118. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., Yi A.-K., Short D., Davis H.L., Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG-motifs, Proc. Natl. Acad. Sci. USA 95 (1998) 12631-12636 [CrossRef] [PubMed].
  119. Krieg A.M., Immune effects and mechanisms of action of CpG motifs, Vaccine 19 (2001) 618-622 [CrossRef].
  120. Kriesel J.D., Spruance J., Calcitriol (1,25-dihydroxy-vitamin D3 coadministered with influenza vaccine does not enhance humoral immunity in human volunteers, Vaccine 17 (1999) 1883-1888 [CrossRef] [PubMed].
  121. Kurata K., Iwata A., Masuda K., Sakaguchi M., Ohno K., Tsujimoto H., Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells, Vet. Immunol. Immunopathol. 102 (2004) 441-450 [PubMed].
  122. Leavell S., Wright B., Scappino L., Sirriyah J., Chen C., Clements J.D., Burkhard M.J., Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag, Vaccine 23 (2005) 1471-1478 [CrossRef] [PubMed].
  123. Lemire J.M., Adams J.S., Sakai R., Jordan S.C., 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood monomorphonuclear cells, J. Clin. Invest. 74 (1984) 657-661 [PubMed].
  124. Letterio J.J., Roberts A.B., Regulation of immune responses by TGF-ß, Annu. Rev. Immunol. 16 (1998) 137-161 [PubMed].
  125. Leutenegger C.M., Boretti F.S., Mislin C.N., Flynn J.N., Schroff M., Habel A., Junghans C., Koenig-Merediz S.A., Sigrist B., Aubert A., Pedersen N.C., Wittig B., Lutz H., Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif, J. Virol. 74 (2000) 10447-10457 [CrossRef] [PubMed].
  126. Lindholm C., Naylor A., Johansson E.L., Quiding-Jarbrink M., Mucosal vaccination increases endothelial expression of mucosal addressin cell adhesion molecule 1 in the human gastrointestinal tract, Infect. Immun. 2 (2004) 1004-1009 [CrossRef].
  127. Lipford G.B., Bauer M., Blank C., Reiter R., Wagner H., Heeg K., CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants, Eur. J. Immunol. 27 (1997) 2340-2344 [PubMed].
  128. Loftager M.K., Eriksen L., Aasted B., Nielsen R., Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2, Res. Vet. Sci. 55 (1993) 281-286 [PubMed].
  129. Lövgren K., Kaberg H., Morein B., An experimental influenza subunit vaccine (ISCOM): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration, Clin. Exp. Immunol. 82 (1990) 435-439 [PubMed].
  130. Lycke N., Severinson E., Strober W., Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation, J. Immunol. 145 (1990) 3316-3324 [PubMed].
  131. Lycke N., Karlsson U., Sjolander A., Magnusson K.E., The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens, Scand. J. Immunol. 33 (1991) 691-698 [PubMed].
  132. Magagnoli C., Manetti R., Fontana M.R., Giannelli V., Giuliani M.M., Rappuoli R., Pizza M., Mutations in the A subunit affect yield, stability, and protease sensitivity on non-toxic derivatives of heat-labile enterotoxin, Infect. Immun. 64 (1996) 5434-5438 [PubMed].
  133. Martin M., Sharpe A., Clements J.D., Michalek S.M., Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli, J. Immunol. 169 (2002) 1744-1752 [PubMed].
  134. Martin-Orozco E., Kobayashi H., Van Uden J., Nguyen M.D., Kornbluth R.S., Raz E., Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences, Int. Immunol. 11 (1999) 1111-1118 [CrossRef] [PubMed].
  135. Mayo S., Royo F., Hau J., Correlation between adjuvanticity and immunogenicity of cholera toxin B subunit in orally immunised young chickens, APMIS 113 (2005) 284-287 [PubMed].
  136. Mayo S.L., Persdotter-Hedlund G., Tufvesson M., Hau J., Systemic immune response of young chickens orally immunized with bovine serum albumin, In vivo 17 (2003) 261-268 [PubMed].
  137. McCluskie M., Davis H.L., CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice, J. Immunol. 161 (1998) 4463-4466 [PubMed].
  138. McGee D.W., Elson C.O., McGhee J.R., Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines, Infect. Immun. 61 (1993) 4637-4644 [PubMed].
  139. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature 388 (1997) 394-397 [CrossRef] [PubMed].
  140. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P., Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide, Oligonucleotides 13 (2003) 245-259 [PubMed].
  141. Minghetti P.P., Norman A.W., 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry, FASEB J. 2 (1988) 3043-3053 [PubMed].
  142. Miyake K., Yamashita Y., Ogata M., Sudo T., Kimoto M., RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family, J. Immunol. 154 (1995) 3333-3340 [PubMed].
  143. Miyake K., Shimazu R., Kondo J., Niki T., Akashi S., Ogata H., Yamashita Y., Miura Y., Kimoto M., Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression, J. Immunol. 161 (1998) 1348-1353 [PubMed].
  144. Mohagheghpour N., Dawson M., Hobbs P., Judd A., Winant R., Dousman L., Waldeck N., Hokama L., Tusé D., Kos F., Benike C., Engleman E., Glucans as immunological adjuvant, Adv. Exp. Med. Biol. 383 (1995) 13-22 [PubMed].
  145. Mowat A.M., Maloy K.J., Donachie A.M., Immune-stimulating complexes as vectors for oral immunization with protein antigens, Immunology 80 (1993) 527-534 [PubMed].
  146. Morein B., Merza M., Vaccination against herpesvirus, fiction or reality? Scand. J. Infect. Dis. (Suppl.) 80 (1991) 110-118.
  147. Morein B., Sundquist B., Höglund S., Dalsgaard K., Osterhaus A., ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses, Nature 308 (1984) 457-460 [CrossRef] [PubMed].
  148. Morein B., Hu K.-F., Abusugra I., Current status and potential application of ISCOMs in veterinary Medicine, Adv. Drug Deliv. Rev. 56 (2004) 1367-1382 [CrossRef] [PubMed].
  149. Munoz E., Zubiaga A.M., Merrow M., Sauter N.P., Huber B.T., Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation, J. Exp. Med. 172 (1990) 95-103 [CrossRef] [PubMed].
  150. Muroi M., Ohnishi T., Tanamoto K., Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B, J. Biol. Chem. 277 (2002) 42372-42379 [CrossRef] [PubMed].
  151. Nashar T.O., Webb H.M., Eaglestone S., Williams N.A., Hirst T.R., Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocytes subsets, Proc. Natl. Acad. Sci. USA 93 (1996) 226-230 [CrossRef] [PubMed].
  152. Nedrud J.G., Sigmund N., Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased, Reg. Immunol. 3 (1990-91) 217-222.
  153. Nguyen T.V., Iosef C., Jeong K., Kim Y., Chang K.O., Lovgren-Bengtsson K., Morein B., Azevedo M.S., Lewis P., Nielsen P., Yuan L., Saif L.J., Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs, Vaccine 21 (2003) 4059-4070 [CrossRef] [PubMed].
  154. Okahashi N., Yamamoto M., Vancott J.L., Chatfield S.N., Roberts M., Bluethmann H., Hiroi T., Kiyono H., McGhee J.R., Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses, Infect. Immun. 64 (1996) 1516-1525 [PubMed].
  155. O'Neal C.M., Clements J.D., Estes M.K., Conner M.E., Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge, J. Virol. 72 (1998) 3390-3393 [PubMed].
  156. O'Neill L.A., Dinarello C.A., The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defence, Immunol. Today 21 (2000) 206-209 [CrossRef] [PubMed].
  157. Pasare C., Medzhitov R., Toll-dependent control mechanisms of CD4 T cell activation, Immunity 21 (2004) 733-741 [CrossRef] [PubMed].
  158. Petrovska L., Lopes L., Simmons C.P., Pizza M., Dougan G., Chain B.M., Modulation of dendritic cell endocytosis and antigen processing pathways by Escherichia coli heat-labile enterotoxin and mutant derivatives, Vaccine 21 (2003) 1445-1454 [CrossRef] [PubMed].
  159. Pierce N.F., Cray W.C. Jr., Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats, J. Immunol. 128 (1982) 1311-1315 [PubMed].
  160. Pisetsky D.S., The immunologic properties of DNA, J. Immunol. 156 (1996) 421-423 [PubMed].
  161. Premier R.R., Jacobs H.J., Lofthouse S.A., Sedgmen B.J., Meeusen E.N., Antibody isotype profiles in serum and circulating antibody-secreting cells following mucosal and peripheral immunisations of sheep, Vet. Immunol. Immunopathol. 98 (2004) 77-84 [PubMed].
  162. Pontarollo R.A., Rankin R., Babiuk L.A., Godson D.L., Griebel P.J., Hecker R., Krieg A.M., van Drunen Littel-van den Hurk S., Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs, Vet. Immunol. Immunopathol. 84 (2002) 43-59 [PubMed].
  163. Provvedini D.M., Rulot C.M., Sobol R.E., Tsoukas C.D., Manolagas S.C., 1 alpha,25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes, J. Bone Miner. Res. 2 (1987) 239-247 [PubMed].
  164. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., Van drunen Little-Van den Hurk S., CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved, Antisense Nucleic Acid Drug Dev. 11 (2001) 333-340 [CrossRef] [PubMed].
  165. Rappuoli R., Pizza M., Douce G., Dougan G., Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins, Immunol. Today 20 (1999) 493-500 [CrossRef] [PubMed].
  166. Rebelatto M.C., Siger L., Hogenesch H., Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves, Res. Vet. Sci. 71 (2001) 9-15 [CrossRef] [PubMed].
  167. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria, Nat. Immunol. 2 (2001) 361-367 [CrossRef] [PubMed].
  168. Reynolds J.A., Kastello M.D., Harrington D.G., Crabbs C.L., Peters C.J., Jemski J.V., Scott G.H., Diluzio N.R., Glucan-induced enhancement of host-resistance to selected infectious diseases, Infect. Immun. 30 (1980) 51-57 [PubMed].
  169. Rogers N.C., Slack E.C., Edwards A.D., Nolte M.A., Schulz O., Schweighoffer E., Williams D.L., Gordon S., Tybulewics V.L., Brown G.D., Reis e Sousa C., Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins, Immunity 22 (2005) 507-517 [CrossRef] [PubMed].
  170. Rolland-Turner M., Farre G., Muller D., Rouet N., Boue F., Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model, Vaccine 22 (2004) 4163-4172 [CrossRef] [PubMed].
  171. Rice P.J., Kelley J.L., Kogan G., Ensley H.E., Kalbfleisch J.H., Browder I.W., Williams D.L., Human monocyte scavenger receptors are pattern recognition receptors for (1g3)-beta-D-glucans, J. Leukoc. Biol. 72 (2002) 140-146 [PubMed].
  172. Ronnberg B., Fekadu M., Morein B., Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix, Vaccine (1995) 1375-1382.
  173. Ross G.D., Vetvicka V., Yan J., Xia Y., Vetvickova J., Therapeutic intervention with complement and beta-glucan in cancer, Immunopharmacology 42 (1999) 61-74 [CrossRef] [PubMed].
  174. Ryan E.J., McNeela E., Pizza M., Rappuoli R., O'Neill L., Mills K.H., Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity, J. Immunol. 165 (2000) 5750-5759 [PubMed].
  175. Salmond R.J., Williams R., Hirst T.R., Williams N.A., Selective induction of CD8+CD4- thymocyte apoptosis mediated by the B-subunit of Escherichia coli heat-labile enterotoxin, Immunol. Lett. 88 (2003) 43-46 [CrossRef] [PubMed].
  176. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., Mohri H., Kensil C.R., Okuda K., Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes, J. Virol. 72 (1998) 4931-4939 [PubMed].
  177. Sheoran A.S., Artiushin S., Timoney J.F., Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin, Vaccine 20 (2002) 1653-1659 [CrossRef] [PubMed].
  178. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4, J. Exp. Med. 189 (1999)1777-1782.
  179. Shreedhar V.K., Kelsall B.L., Neutra M.R., Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches, Infect. Immun. 71 (2003) 504-509 [CrossRef] [PubMed].
  180. Simmons C.P., Mastroeni P., Fowler R., Ghaem-maghami M., Lycke N., Pizza M., Rappuoli R., Dougan G., MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvant, J. Immunol. 163 (1999) 6502-6510 [PubMed].
  181. Singh M., Briones M., O'Hagan D.T., A novel bioadhesive intranasal delivery system for inactivated influenza vaccines, J. Control. Release 70 (2001) 267-276 [CrossRef] [PubMed].
  182. Smith R.E., Donarchie A.M., Grdic D., Lycke N., Mowat A.M., Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses, J. Immunol. 162 (1999) 5536-5546 [PubMed].
  183. Soboll G., Nelson K.M., Leuthner E.S., Clark R.J., Drape R., Macklin M.D., Swain W.F., Olsen C.W., Lunn D.P., Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response, Vaccine 21 (2003) 3081-3092 [CrossRef] [PubMed].
  184. Spangler B.D., Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin, Microbiol. Rev. 56 (1992) 622-647 [PubMed].
  185. Spörri R., Reis e Sousa C., Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function, Nat. Immunol. 6 (2005) 163-170 [CrossRef] [PubMed].
  186. Stambas J., Pietersz G., McKenzie I., Nagabhushanam V., Cheers C., Oxidised mannan-listeriolysin O conjugates induce Th1/Th2 cytokine responses after intranasal immunisation, Vaccine 20 (2002) 1877-1886 [CrossRef] [PubMed].
  187. Stanley A.C., Buxton D., Innes E.A., Huntley J.F., Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep, Vaccine 22 (2004) 3929-3941 [CrossRef] [PubMed].
  188. Stevceva L., Ferrari M.G., Mucosal adjuvants, Curr. Pharm. Des. 11 (2005) 801-811 [CrossRef] [PubMed].
  189. Suckow A., Jarvinend L.S., HogenEsch H., Park K., Bowersock T.L., Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine, J. Control. Release 85 (2002) 227-235 [CrossRef] [PubMed].
  190. Takada A., Kida H., Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus, Vet. Microbiol. 50 (1996) 17-25 [CrossRef] [PubMed].
  191. Takeda K., Akira S., TLR signalling pathways, Semin. Immunol. 16 (2004) 3-9 [CrossRef] [PubMed].
  192. Tamura S., Funato H., Nagamine T., Aizawa C., Kurata T., Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB, Vaccine 7 (1989) 503-505 [CrossRef] [PubMed].
  193. Tamura S., Yajima A., Hatori E., Tamura S., Asanuma H., Suzuki Y., Aizawa C., Kurata T., Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection, Vaccine 15 (1997) 1784-1790 [CrossRef] [PubMed].
  194. Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., Berzofsky J.A., Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMS, Nature 344 (1990) 873-875 [CrossRef] [PubMed].
  195. Thapar M.A., Parr E.L., Parr M.B., The effect of adjuvants on antibody titers in mouse vaginal fluid after intravaginal immunization, J. Reprod. Immunol. 17 (1990) 207-216 [CrossRef] [PubMed].
  196. Tighe H., Takabayashi K., Schwartz D., Van Nest G., Tuck S., Eiden J.J., Kagey-Sobotka A., Creticos P.S., Lichtenstein L.M., Spiegelberg H.L., Raz E., Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity, J. Allergy Clin. Immunol. 106 (2000) 124-134 [CrossRef] [PubMed].
  197. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J., Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14, J. Biol. Chem. 270 (1995) 10482-10488 [CrossRef] [PubMed].
  198. Towers T.L., Freedman L.P., Granulocyte-macrophage colony stimulating factor gene transcription is directly repressed by the vitamin D3 receptor, J. Biol. Chem. 273 (1998) 8483-8491 [CrossRef] [PubMed].
  199. Tsuji N., Miyoshi T., Islam M.K., Isobe T., Yoshihara S., Arakawa T., Matsumoto Y., Yokomizo Y., Recombinant Ascaris 16-Kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs, J. Infect. Dis. 190 (2004) 1812-1820 [CrossRef] [PubMed].
  200. Tudor D., Dubuquoy C., Gaboriau V., Lefevre F., Charley B., Riffault S., TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines, Vaccine 23 (2005) 1258-1264 [CrossRef] [PubMed].
  201. Turanek J., Ledvina M., Kasna A., Vacek A., Hrbalova V., Krejc B., Miller A.D., Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants, Vaccine (2006) in press.
  202. Vajdy M., Lycke N., Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvant, Adv. Exp. Med. Biol. 371B (1995) 1495-1500 [PubMed].
  203. Vancaeneghem S., Cox E., Deprez P., Arnouts S., Goddeeris B.M., ß-glucanen als immunostimulantia en als adjuvantia, Flemish Vet. J. 69 (2000) 412-421.
  204. Van der Stede Y., Cox E., Van den Broeck W., Goddeeris B.M., Enhanced induction of the IgA response in pigs by calcitriol after intramuscular immunization, Vaccine 19 (2001) 1870-1878 [CrossRef] [PubMed].
  205. Van der Stede Y., Verdonck F., Verfaillie T., Cox E., Goddeeris B., CpG-ODN as an effective adjuvant in pigs for intramuscular immunisations, Vet. Immunol. Immunopathol. 86 (2002) 31-41 [PubMed].
  206. Van der Stede Y., Cox E., Verdonck F., Vancaeneghem S., Goddeeris B.M., Reduced faecal excretion of F4+-E coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides, Vaccine 21 (2003) 1023-1032 [CrossRef] [PubMed].
  207. Van Der Stede Y., Verfaillie T., Cox E., Verdonck F., Goddeeris B.M., 1alpha,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization, Clin. Exp. Immunol. 135 (2004) 380-390 [PubMed].
  208. Van der Stede Y., Verdonck F., Verfaillie T., Goddeeris B.M., Cox E., Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases their expression of MHC-II molecules, Vet. Immunol. Immunopathol. 105 (2005) 115-124 [PubMed].
  209. van Pinxteren L.A., Bruce M.G., Campbell I., Wood A., Clarke C.J., Bellman A., Morein B., Snodgrass D.R., Effect of oral rotavirus/ISCOM vaccines on immune responses in gnotobiotic lambs, Vet. Immunol. Immunopathol. 71 (1999) 53-67 [PubMed].
  210. Verdonck F., Snoeck V., Goddeeris B.M., Cox E., Cholera toxin improves the F4(K88)-specific immune response following oral immunization of pigs with recombinant FaeG, Vet. Immunol. Immunopathol. 103 (2005) 21-29 [PubMed].
  211. Verdonck F., De Hauwere V., Bouckaert J., Goddeeris B., Cox E., Fimbriae of enterotoxigenic Escherichia coli function as a mucosal carrier for a coupled heterologous antigen, J. Control. Release 104 (2005) 243-258 [PubMed].
  212. Verfaillie T., Cox E., Goddeeris B.M., Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs, Vet. Immunol. Immunopathol. 103 (2005) 141-151 [PubMed].
  213. Verma M., Majumdar S., Ganguly N.K., Walia B.N., Effect of Escherichia coli enterotoxins on macromolecular absorption, Gut 35 (1994) 1613-1616 [PubMed].
  214. Verminnen K., Van Loock M., Cox E., Goddeeris B., Vanrompay D., Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1$\alpha$,25-dihydroxyvitamin D3, Vaccine 23 (2005) 4509-4516 [CrossRef] [PubMed].
  215. Vervelde L., Janse E.M., Vermeulen A.N., Jeurissen S.H., Induction of a local and systemic immune response using cholera toxin as vehicle to deliver antigen in the lamina propria of the chicken intestine, Vet. Immunol. Immunopathol. 62 (1998) 261-272 [PubMed].
  216. Villacres-Eriksson M., Antigen-presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes, Clin. Exp. Immunol. 102 (1995) 46-52 [PubMed].
  217. Villacres-Eriksson M., Behboudi S., Morgan A.J., Trinchieri G., Morein B., Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response, Cytokine 9 (1997) 73-82 [CrossRef] [PubMed].
  218. Vleugels B., Ververken C., Goddeeris B.M., Stimulatory effect of CpG sequences on humoral response in chickens, Poult. Sci. 81 (2002) 1317-1321 [PubMed].
  219. Wakshull E., Brunke-Reese D., Lindermuth J., Fisette L., Nathans R.S., Crowley J.J., Tufts J.C., Zimmerman J., Mackin W., Adams D.S., PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates a NF-kappa B-like factor in human PMN: evidence for a glycosfingolipid beta-(1,3)-glucan receptor, Immunopharmacology 41 (1999) 89-107 [CrossRef] [PubMed].
  220. Wang D., Kandimalla E.R., Yu D., Tang J.X., Agrawal S., Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity, Vaccine 23 (2005) 2614-2622 [CrossRef] [PubMed].
  221. Wang X., Jiang P., Deen S., Wu J., Liu X., Xu J., Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide, Avian Dis. 47 (2003) 1305-1312 [CrossRef] [PubMed].
  222. Weiner G.J., CpG DNA in cancer immunotherapy, Curr. Top. Microbiol. Immunol. 247 (2000) 157-170 [PubMed].
  223. Weinreich T., Landolt M., Booy C., Wuthrich R., Binswanger U., 1,25-dihydroxyvitamin D3 stimulates transforming growth factor-beta1 synthesis by mouse renal proximal tubular cells, Kidney Blood Press. Res. 22 (1999) 99-105 [CrossRef] [PubMed].
  224. Wernette C.M., Smith B.F., Barksdale Z.L., Hecker R., Baker H.J., CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation, Vet. Immunol. Immunopathol. 84 (2002) 223-236 [PubMed].
  225. Wheeler A.W., Marshall J.S., Ulrich J.T., A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines, Int. Arch. Allergy Immunol. 126 (2001) 135-139 [CrossRef] [PubMed].
  226. Wilkinson J., Rood D., Minior D., Guillard K., Darre M., Silbart L.K., Immune response to a mucosally administered aflatoxin B1 vaccine, Poult. Sci. 82 (2003) 1565-1572 [PubMed].
  227. Williams N.A., Hirst T.R., Nashar T.O., Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic, Immunol. Today 20 (1999) 95-101 [CrossRef] [PubMed].
  228. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C., CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science 249 (1990) 1431-1433 [CrossRef].
  229. Xie H., Raybourne R.B., Babu U.S., Lillehoj H.S., Heckert R.A., CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line, Dev. Comp. Immunol. 27 (2003) 823-834 [PubMed].
  230. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., Elson C.O., Pillai S., McGhee J.R., Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues, J. Exp. Med. 178 (1993) 1309-1320 [CrossRef] [PubMed].
  231. Yamamoto M., Kiyono H., Yamamoto S., Batanero E., Kweon M.N., Azuma M., Takeda Y., McGhee J.R., Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant, J. Immunol. 162 (1999) 7015-7021 [PubMed].
  232. Yamamoto M., Kiyono H., Kweon M.N., Yamamoto S., Fujihashi K., Kurazono H., Imaoka K., Bluethmann H., Takahashi I., Takeda Y., Azuma M., McGhee J.R., Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses, J. Infect. Dis. 182 (2000) 180-190 [CrossRef] [PubMed].
  233. Yazawa N., Fujimoto M., Sato S., Miyake K., Asano N., Nagai Y., et al., CD19 regulates innate immunity by the Toll-like receptor RP105 signaling in B lymphocytes, Blood 102 (2003) 1374-1380 [CrossRef] [PubMed].
  234. Yi A.-K., Chace J.H., Cowdery J.S., Krieg A.M., IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides, J. Immunol. 156 (1996) 558-564 [PubMed].
  235. Yokomizo Y., Watanabe F., Imada Y., Inumaru S., Yanaka T., Tsuji T., Mucosal immunoadjuvant activity of the low toxic recombinant Escherichia coli heat-labile enterotoxin produced by Bacillus brevis for the bacterial subunit or component vaccine in pigs and cattle, Vet. Immunol. Immunopathol. 87 (2002) 291-300 [PubMed].
  236. Yu H., Babiuk L.A., van Drunen Littel-van den Hurk S., Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3, J. Gen. Virol. 85 (2004) 1533-1543 [CrossRef] [PubMed].
  237. Yuan L., Geyer A., Hodgins D.C., Fan Z., Qian Y., Chang K.O., Crawford S.E., Parreno V., Ward L.A., Estes M.K., Conner M.E., Saif L.J., Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs, J. Virol. 74 (2000) 8843-8853 [CrossRef] [PubMed].
  238. Yuan L., Iosef C., Azevedo M.S., Kim Y., Qian Y., Geyer A., Nguyen T.V., Chang K.O., Saif L.J., Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs, J. Virol. 75 (2001) 9229-9238 [CrossRef] [PubMed].
  239. Zarember K.A., Godowski P.J., Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines, J. Immunol. 168 (2002) 554-561 [PubMed].
  240. Zhang Y., Shoda L.K., Brayton K.A., Estes D.M., Palmer G.H., Brown W.C., Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif, J. Interferon Cytokine Res. 21 (2001) 871-881 [PubMed].
  241. Zhu X., Letchworth G.J. III, Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle, Vaccine 14 (1996) 61-69 [CrossRef] [PubMed].